SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001078782-17-000273
Filing Date
2017-03-01
Accepted
2017-02-28 18:59:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A1 f13da1022117_sc13dz.htm SC 13D/A 31408
  Complete submission text file 0001078782-17-000273.txt   32862
Mailing Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022
Business Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Subject) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88107 | Film No.: 17650562
SIC: 2834 Pharmaceutical Preparations

Mailing Address 18 EAST 50TH STREET 5TH FLOOR NEW YORK NY 10022
Business Address 855-232-9953
Sanammad Foundation (Filed by) CIK: 0001604394 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A